- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
NATCO Pharma successfully acquired a 35.75% stake in Adcock Ingram Holdings for approx. US$ 226 million, leading to its delisting from JSE. This strategic move establishes NATCO's market presence in South Africa, aiming for product expansion across Africa.